Kendall Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.38M | Buy |
19,782
+975
| +5% | +$113K | 0.49% | 55 |
|
|
2025
Q4 | $1.98M | Sell |
18,807
-268
| -1% | -$25.2K | 0.41% | 59 |
|
|
2025
Q3 | $1.6M | Buy |
19,075
+1,383
| +8% | +$114K | 0.36% | 68 |
|
|
2025
Q2 | $1.4M | Sell |
17,692
-1,165
| -6% | -$92.6K | 0.37% | 72 |
|
|
2025
Q1 | $1.69M | Sell |
18,857
-492
| -3% | -$45.9K | 0.5% | 54 |
|
|
2024
Q4 | $1.92M | Sell |
19,349
-436
| -2% | -$44.9K | 0.56% | 50 |
|
|
2024
Q3 | $2.25M | Buy |
19,785
+830
| +4% | +$98.6K | 0.69% | 43 |
|
|
2024
Q2 | $2.35M | Buy |
18,955
+1,055
| +6% | +$136K | 0.78% | 32 |
|
|
2024
Q1 | $2.36M | Sell |
17,900
-725
| -4% | -$89.4K | 0.81% | 32 |
|
|
2023
Q4 | $2.03M | Sell |
18,625
-405
| -2% | -$42K | 0.79% | 34 |
|
|
2023
Q3 | $1.96M | Sell |
19,030
-115
| -0.6% | -$12.4K | 0.87% | 33 |
|
|
2023
Q2 | $2.21M | Buy |
19,145
+460
| +2% | +$52.2K | 0.97% | 24 |
|
|
2023
Q1 | $1.99M | Sell |
18,685
-133
| -0.7% | -$14.4K | 0.96% | 26 |
|
|
2022
Q4 | $2.09M | Sell |
18,818
-707
| -4% | -$72.3K | 1.06% | 24 |
|
|
2022
Q3 | $1.68M | Buy |
19,525
+517
| +3% | +$46.2K | 0.98% | 30 |
|
|
2022
Q2 | $1.73M | Buy |
19,008
+375
| +2% | +$33.2K | 0.95% | 34 |
|
|
2022
Q1 | $1.53M | Buy |
18,633
+995
| +6% | +$78.4K | 0.74% | 40 |
|
|
2021
Q4 | $1.35M | Buy |
17,638
+1,400
| +9% | +$112K | 0.64% | 50 |
|
|
2021
Q3 | $1.22M | Buy |
16,238
+1,100
| +7% | +$83.7K | 0.66% | 53 |
|
|
2021
Q2 | $1.18M | Buy |
15,138
+2,622
| +21% | +$195K | 0.66% | 48 |
|
|
2021
Q1 | $921K | Buy |
12,516
+1,718
| +16% | +$127K | 0.57% | 58 |
|
|
2020
Q4 | $843K | Buy |
10,798
+1,677
| +18% | +$128K | 0.61% | 55 |
|
|
2020
Q3 | $722K | Buy |
9,121
+2,500
| +38% | +$196K | 0.63% | 57 |
|
|
2020
Q2 | $489K | Buy |
6,621
+1,666
| +34% | +$125K | 0.47% | 65 |
|
|
2020
Q1 | $364K | Buy |
4,955
+688
| +16% | +$54.1K | 0.41% | 67 |
|
|
2019
Q4 | $370K | Buy |
4,267
+487
| +13% | +$40K | 0.29% | 86 |
|
|
2019
Q3 | $304K | Buy |
3,780
+959
| +34% | +$76.9K | 0.27% | 90 |
|
|
2019
Q2 | $226K | Hold |
2,821
| – | – | 0.2% | 111 |
|
|
2019
Q1 | $224K | Sell |
2,821
-414
| -13% | -$31K | 0.21% | 104 |
|
|
2018
Q4 | $236K | Hold |
3,235
| – | – | 0.24% | 97 |
|
|
2018
Q3 | $219K | Buy |
+3,235
| New | +$206K | 0.19% | 103 |
|
Other funds holding MRK
VCM
VPM
Kendall Capital Management's MRK Position: Q1 2026 in Review
Kendall Capital Management increased its Merck (MRK) stake by 5.2% in Q1 2026, buying an estimated $113K and bringing the position to 19,782 shares worth $2.38M. The position accounts for 0.49% of the portfolio, ranked #55.
Kendall Capital Management first reported a position in MRK in Q3 2018 and has held it in 31 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Kendall Capital Management held 19,782 shares of Merck worth $2.38M as of Q1 2026.
- Kendall Capital Management bought 975 Merck shares in Q1 2026, an estimated $113K.
- Merck made up 0.49% of Kendall Capital Management's portfolio in Q1 2026, its #55 holding.
- Kendall Capital Management first reported a position in Merck in Q3 2018 and has held it in 31 quarters since.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.